[Clinical study on dinoprostone suppositories 0.8 mm used in cervical ripening and labor induction of women with term pregnancy of premature rupture of the membranes: a multicenter study]
- PMID: 21029599
[Clinical study on dinoprostone suppositories 0.8 mm used in cervical ripening and labor induction of women with term pregnancy of premature rupture of the membranes: a multicenter study]
Abstract
Objective: To investigate safety and efficacy of dinoprostone suppositories (0.8 mm) used in cervical ripening and labor induction in women with term premature rupture of the membranes.
Methods: One hundred women of term monocyesis with premature rupture of the membranes, head presentation, bishop score less than 6 (test group) and 180 women with intact fetal membranes (control group) were enrolled into this multicenter, prospective clinical study. The vaginal delivery system was inserted into the posterior fornix, and the patients were recumbent for 2 hours after insertion. The interval time from using dinoprostone suppositories to uterine contraction, to labor and delivery were recorded. The following index were also recorded and compared, including the mean inserted time of dinoprostone suppositories, fetal heart beat, meconium stained amniotic fluid, hyperstimulation of uterus and the other complications, mode of delivery, stage of labor, postpartum hemorrhage, status of neonates.
Results: Three cases in test group and 23 cases in control group weren't in labor within 24 hours. The rate of labor within 24 hours in test group was significant higher than that in control group (97.0% vs. 87.2%, P < 0.01). It was observed that 73 cases undergoing vaginal deliveries (75.3%, 73/97) and 24 cases undergoing cesarean section deliveries (24.7%, 24/97)in test group and 107 cases undergoing vaginal delivery (68.2%, 107/157) and 50 cases undergoing cesarean section delivery (31.8%, 50/157) in control group, when compared the rate of vaginal or cesarean section deliveries between two group, it didn't reach statistical difference (P > 0.05). It had no significant difference in the interval time from using dinoprostone suppositories to labor starting and the mean inserted time and the total labor time between two groups (P > 0.05). The incidence of uterine tachysystole was 11.3% (11/97) in test group and 19.1% (30/157) in control group (P > 0.05), which did not reach statistical difference (P > 0.05). There wasn't neonatal asphyxia in both groups.
Conclusion: It was safe and efficient to use dinoprostone suppositories for cervical ripening and induction of term pregnancy with premature rupture of the membranes, however, monitoring should be intensified.
Similar articles
-
A randomized clinical trial to compare the efficacy of different doses of intravaginal misoprostol with intracervical dinoprostone for cervical ripening and labor induction.Eur Rev Med Pharmacol Sci. 2011 Jul;15(7):759-63. Eur Rev Med Pharmacol Sci. 2011. PMID: 21780543 Clinical Trial.
-
Vaginal misoprostol in managing premature rupture of membranes.East Mediterr Health J. 2002 Jul-Sep;8(4-5):515-20. East Mediterr Health J. 2002. PMID: 15603033 Clinical Trial.
-
Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary.J Matern Fetal Neonatal Med. 2003 Sep;14(3):158-62. doi: 10.1080/jmf.14.3.158.162. J Matern Fetal Neonatal Med. 2003. PMID: 14694970 Clinical Trial.
-
Methods for cervical ripening and induction of labor.Am Fam Physician. 2003 May 15;67(10):2123-8. Am Fam Physician. 2003. PMID: 12776961 Review.
-
Vaginal misoprostol administration for cervical ripening and labor induction.Clin Obstet Gynecol. 2006 Sep;49(3):627-41. doi: 10.1097/00003081-200609000-00021. Clin Obstet Gynecol. 2006. PMID: 16885668 Review.
Cited by
-
Clinical parameters for prediction of successful labor induction after application of intravaginal dinoprostone in nulliparous Chinese women.Med Sci Monit. 2012 Aug;18(8):CR518-522. doi: 10.12659/msm.883273. Med Sci Monit. 2012. PMID: 22847202 Free PMC article.
-
[Clinical efficacy and safety of controlled-release dinoprostone insert: a multicenter retrospective study].Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jan 20;37(1):18-23. doi: 10.3969/j.issn.1673-4254.2017.01.04. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28109093 Free PMC article. Chinese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources